US 10946049
Use of gram negative species to treat atopic dermatitis
granted A61KA61K35/74A61K9/0014
Quick answer
US patent 10946049 (Use of gram negative species to treat atopic dermatitis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/74, A61K9/0014, A61K9/06, A61P